Intellectual property and purine drug development platform

intellectual property and purine drug development platform Dr bridget bax is a reader in rare diseases her research focuses on identifying the molecular mechanisms that contribute to the pathology of the ultra-rare disease, mitochondrial neurogastrointestinal encephalomyopathy (mngie), and the development of a cell-based enzyme replacement for the treatment of patients with mngie.

Brief history purinex, inc is a drug-discovery and drug-development company based in syracuse, new york it sought to commercialize therapeutic compounds based on its purine drug-development platform purinex’s goal was to develop products that evoked a receptor-specific pharmacodynamic effect without producing undesirable outcomes that could result from interactions with other receptors. Kfb and rrb are cofounders of biorelix, a company that is pursuing intellectual property related to the use of riboswitches as drug targets references 1. Intellectual property essays and research papers | examplesessaytodaybiz intellectual property and purine drug-development platform what is purinex’s business the development of intellectual property law in the united states has also followed the development of american law in general as america moved into and through the. Inventor p 诺 r 尼格 k 利 早内丰 original assignee 拜耳知识产权有限责任公司 priority date (the priority date is an assumption and is. Friday, april 19 for the past four years, aspet members attending the aspet annual meeting at eb 2013 have spent a day volunteering in the local communities of the host city: in 2009, we built homes with habitat for humanity in the upper 9th ward in new orleans in 2010, 2011, and 2012 we prepared and served meals to homeless residents of pasadena, washington, dc, and san diego, respectively.

Drug development platform purine was naturally occurring molecule that acted as selective agonists (activators) or antagonists (blockers) for specific purine purinex’s intellectual-property portfolio consisted among the reasons for the high r&d costs was that the drug development and approval process was lengthy and risky the. Drug development platform purine was naturally occurring molecule that acted as selective agonists (activators) or antagonists (blockers) for specific purine purinex’s intellectual-property portfolio consisted documents similar to purinex case minor problems uploaded by apollo manalo gainesboro_case_analysis uploaded by. Background: many protein kinases are targets for inhibition during drug discoverymost first generation inhibitors bind at a site used by the purine moiety of atp and were discovered in assays following inhibition of activated forms of protein kinases, often using model substrates.

We synthesized three chelate-tethered purine ligands, having a schiff base linkage at the n9 position, which resulted in the dipolar imine-methoxyphenol adenine schiff base hl1, the 2-aminopurine. • responsible for scientific and strategic evaluation of m&a and in-licensing opportunities, including the october, 2004 acquisition of the clinical and intellectual property assets of biorex research and development company including three clinical stage oral drug candidates and the june 2008 acquisition of innovive pharmaceuticals with four. Dignify therapeutics is a venture-backed drug development company focused on developing novel bladder and bowel drug therapies for spinal cord injured, spina bifida, multiple sclerosis and other patient populations with voiding dysfunction. Glaxosmithkline intellectual property (no2) limited (brentford, middlesex, gb) lindsley c, development of a custom high-throughput preparative liquid chromatography/mass spectrometer platform for the preparative purification and analytical analysis the dosage of the inventive compounds may be adjusted for any drug-drug. Purine sensing by riboswitches jane n kim 1 and ronald r breaker 1,2,3, article first published online: 9 jan 2012 and the guanine riboswitches in some bacteria might be suitable targets for drug development aspects of the complex functions and the possible applications of purine riboswitches are outlined below rrb is a.

Inhibition of histone demethylases provides an alternative pathway for repressing herpes virus infection as compared to purine analog antivirals while purine analogs are the most widely prescribed treatment for herpes infection, drug resistance is prevalent. Use of cereblon-associated proteins as biomarkers for clinical sensitivity to cancer, inflammatory diseases, and patient response to drug treatment. Case facts purinex was a drug-discovery and -development company based in syracuse, new york, that sought to commercialize therapeutic compounds based on its purine drug-development platform purine was a naturally occurring molecule that played an important role in numerous biochemical processes. Our ability to obtain and adequately protect intellectual property rights for our product candidates of the natural biology of listeria that make it an attractive platform for immuno-oncology drug development, foreign patent applications directed to stereochemically pure cyclic purine dinucleotides and certain other substituted cyclic.

Glaxosmithkline plc (gsk) is a british pharmaceutical company headquartered in brentford, london established in 2000 by a merger of glaxo wellcome and smithkline beecham, gsk was the world's sixth largest pharmaceutical company as of 2015, after pfizer . Purinex was a drug-discovery and -development company based in syracuse, new york, that sought to commercialize therapeutic compounds based on its purine drug-development platform. Purinex, inc purinex was a drug-discovery and -development company based in syracuse, new york, that sought to commercialize therapeutic compounds based on its purine drug-development platform purine was a naturally occurring molecule that played an important role in numerous purinex’s intellectual-property portfolio consisted of more.

Intellectual property and purine drug development platform

Specialties: scientific strategy and planning, translating decisions into operational plans, highly organized, results orientated project management style, intellectual property management. Browse over 1 million classes created by top students, professors, publishers, and experts, spanning the world's body of learnable knowledge. Genzyme says abon — a small drug development company specializing in drug delivery research and product development — has filed an abbreviated new drug application with the us food and drug.

Market analysis is an important component of analytical system in retail companies to determine the sales for different segments of customers to improve customer satisfaction and to increase profit of the company which has different channels and regions. Probing of biology with molecules, and intellectual property should be protected around the key molecules themselves—what black called the drug invention (as opposed to discovery. These services are provided under strict intellectual property protection guarded by confidentiality agreements with our clients the goal is to provide reliable and strong platform to our customers, enabling them to accelerate their nce & api's development programme, efficiently and cost effectively.

Assessing the directions of drug development is somewhat daunting, as pharmaceutical companies perform their research and development behind closed doors to protect intellectual property rights and potential market shares of innovative new agents. Furthermore, riboswitches that control the expression of key metabolic genes might serve as targets for antibacterial compounds, and the guanine riboswitches in some bacteria might be suitable targets for drug development. Neotherapeutics, inc (irvine, ca 949- 788-6700) announced that the company has been allowed a united states patent covering the use of purine derivates, such as neotrofin, to selectively activate or depress genes encoding for molecules such as neurotrophic factors.

intellectual property and purine drug development platform Dr bridget bax is a reader in rare diseases her research focuses on identifying the molecular mechanisms that contribute to the pathology of the ultra-rare disease, mitochondrial neurogastrointestinal encephalomyopathy (mngie), and the development of a cell-based enzyme replacement for the treatment of patients with mngie.
Intellectual property and purine drug development platform
Rated 3/5 based on 50 review

2018.